Efficacy and Safety of Rechallenge [177Lu]lu-Psma-617 RLT after Initial Partial Remission in Patients with Mcrpc: Evaluation of a Prospective Registry (REALITY Study).
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2024）
Key words
Rechallenge,PSMA,Radioligand therapy,177Lu,mCRPC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined